Faber J, Kirkegaard C, Jørgensen B, Kludt J
Department of Medicine E and Clinical Chemistry, Frederiksberg Hospital, Denmark.
Acta Endocrinol (Copenh). 1989 May;120(5):667-71. doi: 10.1530/acta.0.1200667.
The validity of estimation of the production rates of T3 and rT3 in man based on noncompartmental analysis of blood-derived data has been questioned owing to incomplete exchangeability of T3 and rT3 between plasma and extrathyroidal tissues in which a local production of these iodothyronines takes place. The possible existence of a nonexchangeable or hidden pool of T3 and rT3 would result in an underestimation of the daily production. By contrast, the production rate of T4 can be estimated reliably using noncompartmental analysis. We have studied 16 women with pretreatment severe hypothyroidism on constant levothyroxine therapy. Simultaneous measurements of T4, T3 and rT3 production rates were performed using bolus injection of radiolabelled iodothyronines. The tracers were isolated from plasma using gel separation/antibody extraction, and production rates were calculated by noncompartmental analysis. Mean (+/- SD) production rate of T4, T3 and rT3 were: 119 +/- 43, 40.0 +/- 22.0 and 54.9 +/- 20.0 nmol.day-1.(70 kg)-1, respectively. Thus 79.5 +/- 7.0% of T4 was deiodinated into T3 and rT3. This leaves 20.5% to other metabolic pathways of T4 and to a possible underestimation of T3 and rT3 production rate. Based on conservative estimates from the literature, the other metabolic pathways of T4 amount: oxidative deamination 1.1%; ether link cleavage 0%; urinary excretion 2.5%; and fecal excretion 14%. Thus, the various metabolic pathways seem to explain 97% of daily produced and degradated T4 in man. Therefore the understimation of T3 and rT3 production rates in man using noncompartmental analysis seems of little if any importance, and existence of a hidden pool of these iodothyronines may be questioned.
基于对血液衍生数据的非房室分析来估计人体中T3和反T3生成率的有效性受到了质疑,这是因为T3和反T3在血浆与甲状腺外组织(这些碘甲状腺原氨酸在此处进行局部生成)之间的交换不完全。T3和反T3可能存在不可交换或隐藏池,这会导致每日生成量的低估。相比之下,使用非房室分析可以可靠地估计T4的生成率。我们研究了16名接受左甲状腺素持续治疗的重度甲状腺功能减退症女性患者,她们在治疗前病情严重。通过静脉注射放射性标记的碘甲状腺原氨酸,同时测量T4、T3和反T3的生成率。使用凝胶分离/抗体提取从血浆中分离出示踪剂,并通过非房室分析计算生成率。T4、T3和反T3的平均(±标准差)生成率分别为:119±43、40.0±22.0和54.9±20.0 nmol·天⁻¹·(70 kg)⁻¹。因此,79.5±7.0%的T4脱碘生成T3和反T3。这使得20.5%的T4进入其他代谢途径,并可能低估T3和反T3的生成率。根据文献的保守估计,T4的其他代谢途径占比为:氧化脱氨基1.1%;醚键断裂0%;尿排泄2.5%;粪便排泄14%。因此,各种代谢途径似乎解释了人体中每日生成和降解的T4的97%。所以,使用非房室分析低估人体中T3和反T3的生成率似乎并不重要,这些碘甲状腺原氨酸隐藏池的存在可能受到质疑。